Clinical Trial Committee

Clinical Trials Technical Committee

The Clinical Trials Technical Committee (CTTC) has been established by Director General under Section 13 of TMDA Act, Cap 219 to provide independent technical advice to the Director General.

The CTTC provides technical advice to ensure that clinical trials are designed, conducted, analyzed and reported by TMDA and ICH guidelines. In this respect, their recommendations are expected to be scientific and evidence-based.

Members of the Clinical Trial Technical Committee (CTTC) are expected to be prudent, transparent, independent, and committed to their professional ethics while discussing all matters pertaining to clinical trials.

Composition of the Committee

The CTTC is composed of experts with knowledge and experience in at least any of the following fields: Clinical Trials, Medical Research, Clinical Pharmacology, Clinical Epidemiology, Medicine, Dental Surgery, Pharmacy, Medical Statistics, Public Health, Toxicology, Microbiology, Pathology and Regulatory Affairs

The CTTC meets once quarterly and the current members are as listed in the table;

NoNameTitleBackground/ Field
1.Dr. Doreen MlokaChair PersonPharmaceutical Microbiology
2.Dr. Yonah H. MwalwisiSecretaryPharmacy and Regulatory Affairs
3.Dr. Billy NgasalaMemberParasitology and Medical Entomology
4.Prof. Mecky MateeMemberMicrobiology
5.Dr. Omar LwenoMemberEpidemiology/ Clinical Trials
6.Dr. Jenifa MetodiMemberPaediatrics
7.Dr. Mwanaidi KafuyeMemberResearch ethics/ Immunology and microbiology
8.Dr. Hadija MalimaMemberResearch ethics/ Epidemiology
9.Prof. Patricia MunseriMemberInternal Medicine /Clinical Trials

The Committee serves for three (3) years and the tenure of the current Committee will come to an end on 31st January, 2025.